Summary
This 8-K filing from Abbott Laboratories, dated January 17, 2001, reports on the company's financial results for the fourth quarter and the full year 2000. The primary event disclosed is the issuance of a press release detailing these financial outcomes. Investors can find comprehensive sales and earnings figures for the periods ending December 31, 2000, within this attached press release, which serves as the core informational component of this filing. The filing itself is brief, directing readers to the attached Exhibit 99.1 for the substantive financial data. While the 8-K doesn't provide the specific figures directly, it signals the official release of important performance metrics. Shareholders and potential investors should consult the January 16, 2001 press release for a detailed understanding of Abbott's recent financial performance and trends.
Key Highlights
- 1Abbott Laboratories filed an 8-K on January 17, 2001, reporting on its financial performance.
- 2The filing primarily announces the release of a press release detailing fourth-quarter and full-year 2000 sales and earnings.
- 3The press release, dated January 16, 2001, is included as Exhibit 99.1 to the 8-K.
- 4This report serves as the official notification of Abbott's financial results for the period ending December 31, 2000.
- 5Investors are directed to the press release for specific sales and earnings figures.